8015-6286 Screening compound: N~1~-[(Z)-1-({[2-(1H-1,3-benzimidazol-2-yl)ethyl]amino}carbonyl)-2-(4-chlorophenyl)-1-ethenyl]-4-isobutoxybenzamide

8015-6286 Screening compound: N~1~-[(Z)-1-({[2-(1H-1,3-benzimidazol-2-yl)ethyl]amino}carbonyl)-2-(4-chlorophenyl)-1-ethenyl]-4-isobutoxybenzamide
8015-6286 Screening compound: N~1~-[(Z)-1-({[2-(1H-1,3-benzimidazol-2-yl)ethyl]amino}carbonyl)-2-(4-chlorophenyl)-1-ethenyl]-4-isobutoxybenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 8015-6286
N~1~-[(Z)-1-({[2-(1H-1,3-benzimidazol-2-yl)ethyl]amino}carbonyl)-2-(4-chlorophenyl)-1-ethenyl]-4-isobutoxybenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

8015-6286

Molecular Formula

C29H29ClN4O3 (C29 H29 ClN4 O3)

Compound Name

N~1~-[(Z)-1-({[2-(1H-1,3-benzimidazol-2-yl)ethyl]amino}carbonyl)-2-(4-chlorophenyl)-1-ethenyl]-4-isobutoxybenzamide

IUPAC name

(2Z)-N-[2-(1H-13-benzodiazol-2-yl)ethyl]-3-(4-chlorophenyl)-2-{[4-(2-methylpropoxy)phenyl]formamido}prop-2-enamide

SMILES

CC(C)COc(cc1)ccc1C(N/C(/C(NCCc1nc(cccc2)c2[nH]1)=O)=C\c(cc1)ccc1Cl)=O

InChI

InChI=1S/C29H29ClN4O3/c1-19(2)18-37-23-13-9-21(10-14-23)28(35)34-26(17-20-7-11-22(30)12-8-20)29(36)31-16-15-27-32-24-5-3-4-6-25(24)33-27/h3-14,17,19H,15-16,18H2,1-2H3,(H,31,36)(H,32,33)(H,34,35)

InChI Key

WFOTYNRSQHUHHG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05257212

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

517.03

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.636

Distribution Coefficient, logD

4.875

Water Solubility, LogSw

-6.22

Polar Surface Area

74.199

Acid Dissociation Constant (pKa)

6.72

Base Dissociation Constant (pKb)

4.70

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.69

8015-6286 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Kinases
  • Phosphatases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 8015-6286 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 8015-6286?
Check Price and Availability of 8015-6286, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 8015-6286 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 8015-6286
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 8015-6286
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 8015-6286 available by request